It has been reported that FGF21 had therapeutic effects on glucose and lipid metabolism in mice [121] and especially, long-acting FGF21 (PF-05231023) improved the levels of the circulating lipid profile in type 2 diabetic patients and in obese cynomolgus monkeys [122]. Here, FGF21 is linked to type 2 diabetes mellitus.